Litigation
-
Representations and the limits of deceit in M&A transactions
The judgment sends a powerful message about the limits of deceit in heavily negotiated M&A transactions and the high threshold for these types of claims.
-
What the ECJ’s landmark ruling on defective products liability means for life sciences manufacturers
This article covers the expanded litigation risk, the steps life science companies should take to reinforce their product safety, and risk‑management governance.
-
Website tracking, data breaches, and AI class actions
Managing escalating technology litigation risk.
-
Victims of cryptocurrency theft cannot pursue claims in conversion
The judgment raises the question of whether there should be legislation to make a conversion-like cause of action apply to cryptocurrency.
-
FINRA opens broad review of arbitration process
The move signals an impending reboot of an often-criticized system.
-
When AI meets privilege: Early court decisions
How privilege claims should be managed when AI is involved.
-
Changing UK product liability law: potential effects on the healthcare sector
Proactive steps companies in the healthcare sector (or those that insure or invest in those businesses) should take now.
-
UK Supreme Court delivers landmark ruling on AI patentability
The decision has significant implications for the patentability of computer-implemented inventions in UK sectors especially healthcare and life sciences.